Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey A Strong

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Case Reports in Ophthalmology|October 11, 2016
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case ReportStacey A Strong, Avinash Gurbaxani, Michel Michaelides
The British Journal of Ophthalmology|May 1, 2018
Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitorsStacey A Strong, Nashila Hirji, Ana Quartilho, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 26, 2010
Prandial presbyopiaAllon Barsam, Devinder S Chauhan, Stacey A Strong, et al.
Eye (London, England)|February 24, 2022
Is preventable sight loss truly preventable? An exploration of a public health indicator for sight loss due to age-related macular degeneration in EnglandKelsey Brown, Catey Bunce, Oluwaseun Onabanjo, et al.
The British Journal of Ophthalmology|February 12, 2020
Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosaStacey A Strong, Tunde Peto, Catey Bunce, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Case Reports in Ophthalmology|October 11, 2016
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case ReportStacey A Strong, Avinash Gurbaxani, Michel Michaelides
The British Journal of Ophthalmology|May 1, 2018
Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitorsStacey A Strong, Nashila Hirji, Ana Quartilho, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 26, 2010
Prandial presbyopiaAllon Barsam, Devinder S Chauhan, Stacey A Strong, et al.
Eye (London, England)|February 24, 2022
Is preventable sight loss truly preventable? An exploration of a public health indicator for sight loss due to age-related macular degeneration in EnglandKelsey Brown, Catey Bunce, Oluwaseun Onabanjo, et al.
The British Journal of Ophthalmology|February 12, 2020
Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosaStacey A Strong, Tunde Peto, Catey Bunce, et al.
Pageof 1